| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.57 | 0.05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.093 | 0.06 |